Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02776228Phase 3Unknown
Phase 3, randomised, double-blind trial of brotizolam in Insomnia (2 arms), sponsored by Rambam Health Care Campus. Primary endpoint: Assessing chronic insomnia at 1 year. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02776228.